性ホルモンが喘息重症度差を説明する免疫応答に関連(Sex hormones linked to immune responses that may help explain differences in asthma severity)

ad

2026-02-11 インペリアル・カレッジ・ロンドン(ICL)

インペリアル・カレッジ・ロンドンの研究チームは、性ホルモンが免疫応答に影響を与え、喘息の重症度における男女差を説明し得ることを示した。研究では患者データと免疫細胞解析を組み合わせ、エストロゲンやテストステロンが炎症関連経路や免疫細胞の活性化に異なる作用を及ぼすことを確認。特に特定の免疫シグナルがホルモン環境により増強または抑制され、症状の悪化リスクに関与する可能性が示唆された。これらの知見は、性差を考慮した個別化治療や新規治療標的の開発に重要な基盤を提供する。

<関連情報>

上皮成長因子受容体は、吸入アレルゲンに対する肺の2型反応における性差を制御する Epidermal growth factor receptor controls sex differences in lung type 2 responses to inhaled allergen

Helen Stölting, April L. Raftery, Simone A. Walker, Eimear N. Rutherford, […] , and Clare M. Lloyd
Science Immunology  Published:23 Jan 2026
DOI:https://doi.org/10.1126/sciimmunol.adk1673

性ホルモンが喘息重症度差を説明する免疫応答に関連(Sex hormones linked to immune responses that may help explain differences in asthma severity)

Editor’s summary

The frequency and severity of asthma are higher in adult females compared with males, and periods of hormonal change—such as puberty, pregnancy, and menopause—are associated with the modulation of symptoms. Stölting et al. report that female mice exposed to house dust mite (HDM) aeroallergens starting early in life show enhanced type 2 airway responses compared with males. The female hormone 17β-estradiol (E2) amplifies the production of interleukin-33 (IL-33) by fibroblasts. This, in turn, drives the up-regulation of epidermal growth factor receptor (EGFR) expression on T helper 2 (TH2) cells, which then boosts their secretion of T2 cytokines. EGFR may therefore serve as a bridge linking hormonal disruptions and asthma severity in females. —Seth Thomas Scanlon

Abstract

Hormonal disruptions are associated with poor asthma control in females, yet how these phenomena are linked remains unknown. Here, we investigated distinct allergen-induced immune responses between the sexes during maturation. By 6 weeks of life, female mice exposed to the aeroallergen house dust mite (HDM) from postnatal day 7 exhibited stronger type 2 (T2) immune responses and higher lung interleukin-33 (IL-33) than males. IL-33 administration to HDM-sensitized males was sufficient to augment T2 immunity and up-regulated epidermal growth factor receptor (EGFR) on T helper 2 (TH2) cells. EGFR inhibition abrogated T2 cytokine production in vitro. In vivo, EGFR inhibition reduced T2 immunity in females only, thereby abolishing any sex differences. 17β-estradiol (E2) heightened lung Il33 expression and T2 responses of HDM-sensitized males, akin to levels in females. EGFR’s ability to drive sex differences in lung T2 responses downstream of E2 and IL-33 may link hormonal disruptions to poor asthma control.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました